Monthly information on share capital and company voting rights
Rhea-AI Summary
Cellectis (CLLS) has released its monthly update on share capital and voting rights as of August 31, 2024. The company reported a total of 100,093,635 shares in the capital and 88,029,440 voting rights. This information is disclosed in compliance with Article 223-16 of the General Regulation of the French financial markets authority. Cellectis is listed on the Euronext Growth market under the ISIN code FR0010425595.
For investors seeking further information, Cellectis has provided contact details for media and investor relations inquiries. This regular disclosure helps maintain transparency and keeps shareholders informed about the company's capital structure.
Positive
- Transparency in reporting share capital and voting rights
- Compliance with French financial market regulations
Negative
- None.
News Market Reaction 1 Alert
On the day this news was published, CLLS declined 1.30%, reflecting a mild negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
(Article 223-16 of General Regulation of the French financial markets authority)
PARIS, Sept. 04, 2024 (GLOBE NEWSWIRE) --
Listing market: Euronext Growth
ISIN code: FR0010425595
| Date | Total number of shares in the capital | Total number of voting rights |
| 08/31/2024 | 100,093,635 | 88,029,440 |
For further information on Cellectis, please contact:
Media contact:
Pascalyne Wilson, Director, Communications, +33 (0)7 76 99 14 33, media@cellectis.com
Patricia Sosa Navarro, Chief of Staff to the CEO, +33 (0)7 76 77 46 93
Investor Relations contacts:
Arthur Stril, Interim Chief Financial Officer, +1 (347) 809 5980, investors@cellectis.com
Attachment
FAQ
How many shares does Cellectis (CLLS) have as of August 31, 2024?
What is the total number of voting rights for Cellectis (CLLS) as of August 31, 2024?
On which market is Cellectis (CLLS) listed?
What is the ISIN code for Cellectis (CLLS) stock?
